about
Epilepsy in patients with duplications of chromosome 14 harboring FOXG1.Ictal vomiting as a sign of temporal lobe epilepsy confirmed by stereo-EEG and surgical outcome.Migraine equivalents and related symptoms, psychological profile and headache features: which relationship?Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease.Therapeutic approach to epileptic encephalopathies.O016. Does migraine follow benign paroxysmal torticollis?Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas.Role of the Attachment Style in Determining the Association Between Headache Features and Psychological Symptoms in Migraine Children and Adolescents. An Analytical Observational Case-Control Study.Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.Paediatric anti-N-methyl-D-aspartate receptor encephalitis: The first Italian multicenter case series.Focal seizures versus epileptic spasms in children with focal cortical dysplasia and epilepsy onset in the first year.O019. Headache as an emergency in children and adolescentsClinical studies and anti-inflammatory mechanisms of treatments.Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABAAR antibodies.Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.Dyskinesia as a new adverse effect of hormonal treatment in West syndrome.Cognitive development in females with PCDH19 gene-related epilepsy.Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia.Maternal Alexithymia and Attachment Style: Which Relationship with Their Children's Headache Features and Psychological Profile?Hemiconvulsion-Hemiplegia-Epilepsy syndrome associated with inflammatory-degenerative hystopathological findings in child with congenital adrenal hyperplasia.Non-motor symptoms in movement disorders: more than meets the eyeSuccessful use of fenfluramine in nonconvulsive status epilepticus of Dravet syndromePediatric status epilepticus: Identification of prognostic factors using the new ILAE classification after 5 years of follow-upDravet syndrome: Treatment options and management of prolonged seizures
P50
Q30800412-FDD9052D-2D45-4AD0-9A5D-DB888F70F682Q31021639-CFFDF635-259F-48EA-908B-30F8742D051CQ35743664-95F77F94-1FE1-490D-B987-3F3025D3273DQ36410201-DB8F5424-2CC2-444C-9ADF-6BD1B03CCA2CQ38191250-769428C3-25DE-4D10-99DD-C78881431CEDQ38553467-5EE83FB3-F5FB-4122-9894-004D94092670Q38978337-0B129121-710D-4C81-BBD1-346C0DC64E56Q39036852-0FCAE3C2-2E1A-4E22-A46F-6A8E2A890807Q40177841-A4EC79AA-003E-43E5-B7A9-96517E0BD219Q41190154-D225188F-DDAA-4E7A-9C6C-9B11F3B10B1CQ41668921-92B30DD4-4AC0-439E-8562-2709900B71D7Q41869999-B5057DF0-3564-407E-AD87-CE4FCDB7458AQ47124754-02BC961B-FC41-4AE8-94B1-907525E1CB4DQ47224677-5879B083-E1B2-404D-B957-8A3BFE1FA30AQ48029900-D452AA25-6E22-43B3-B47F-DCD43C5CCE16Q48124471-FAD8B082-00DB-4FD9-A795-ED45E79D05D9Q48153761-782FBB1F-2527-4A95-96D1-C4283787AC1EQ48385961-73BA2675-5E95-4717-B86A-3DA23FED1ED1Q49314057-08BFE4E3-3C88-4CEF-A40D-1F8135724F41Q54417191-BEA0CB40-945B-459C-9D3C-81E7DF493586Q89961007-41DD173B-5614-44A2-915C-4CA90CF0E4ADQ90297352-26B0F9FA-0BC1-460A-A899-948A0BC6C345Q91265644-62D36AAF-C43C-4F1B-8480-F969ECBA3237Q92431661-3DBDA7A2-217D-4D98-BE80-00CA540DEB90
P50
description
researcher
@en
name
Federico Vigevano
@en
type
label
Federico Vigevano
@en
prefLabel
Federico Vigevano
@en
P31
P496
0000-0001-7513-0051